A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Posaconazole Impurity 121 - Request Quote

Picture of Posaconazole Impurity 121

Posaconazole Impurity 121

SZ CAT No:SZ-P022171
CAS No
NA
Mol.F.
C13H14F2O3
Mol.Wt.
256.2
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Posaconazole Impurity 121 is chemically Methyl 4-(2,4-difluorophenyl)-2-(hydroxymethyl)pent-4-enoate. Posaconazole Impurity 121 is supplied with detailed characterization data compliant with regulatory guideline. Posaconazole Impurity 121 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Posaconazole.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Posaconazole Impurity 121

Purchase Posaconazole Impurity 121

Posaconazole Impurity 121 suppliers

Posaconazole Impurity 121 manufacturers

Posaconazole Impurity 121 price

Order Posaconazole Impurity 121

Enquire Posaconazole Impurity 121

Posaconazole Impurity 121 cost

Posaconazole Impurity 121 Supplier

Posaconazole Impurity 121 Distributor

Posaconazole Impurity 121 for Method Validation

Posaconazole Reference Standard

Posaconazole Impurity 121 for ANDA Filing

Posaconazole Impurity 121 for Forced Degradation Studies

Posaconazole Impurity 121 Identification Standards

Posaconazole Impurity 121 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,